How Can Pharma Companies Get the Most Out of a Platform Approach?

With new platform technologies emerging, there is an opportunity to elevate pharma’s digital initiatives to a more flexible and globally compliant framework that can scale across multiple markets and therapy areas. By moving beyond a product-by-product approach, to platform strategies with interoperable data architectures, digital health teams have an opportunity to help pharma overcome siloed strategies. To enable this, digital team members must be well-versed in what it takes to future-proof their approach, while still delivering meaningful value to patients, clinicians, and the organisation. If you are interested in learning how you can implement a scalable and compliant platform-based approach into your digital strategies, join this meeting with Nayan Kalnad (Co-founder and CEO at Avegen) to discuss:

• How can pharma leverage a platform approach when building digital health products?
• How might implementing a platform-based strategy benefit pharma?
• How can pharma maximise the commercial value of these strategies?
• What are some necessary tactics to achieve cross-organisation stakeholder alignment on a platform approach?